EUROPEAN MEDICINES AGENCY APPROVED APIXABAN USE IN CARDIOVERSION
Abstract
European Medicines Agency approved apixaban use in cardioversion.
Review
For citations:
EUROPEAN MEDICINES AGENCY APPROVED APIXABAN USE IN CARDIOVERSION. Rational Pharmacotherapy in Cardiology. 2014;10(3):360. (In Russ.)
Views:
532
Email this article 